Kirkland & Ellis counseled Orion Biotech Opportunities Corp. on the deal. Orion Biotech Opportunities Corp. closed its initial public offering (IPO) of 20,000,000 units at a price of...
Kirkland & Ellis counseled Orion Biotech Opportunities Corp. on the deal. Orion Biotech Opportunities Corp. closed its initial public offering (IPO) of 20,000,000 units at a price of...
You must be a Standard 1 Year member to access this content.